Bavarian Nordic Repurchases DKK 7.1M in Shares Under New Buyback Program
Event summary
- Bavarian Nordic repurchased 40,086 shares for DKK 7.1M under a new buyback program launched March 12, 2026.
- Average purchase price was DKK 177.15 per share, with transactions executed by Nordea.
- Post-repurchase, Bavarian Nordic holds 1,737,847 treasury shares (2.19% of share capital).
- Program runs until May 13, 2026, with a total allocation of up to DKK 200M.
The big picture
Bavarian Nordic's share buyback program, launched amid a period of strategic capital allocation, reflects a broader trend among biotech firms to return value to shareholders in the absence of immediate M&A opportunities. The move comes as the company solidifies its position as a preferred supplier of mpox and smallpox vaccines, though its execution will be closely watched given the program's size relative to its market cap.
What we're watching
- Capital Allocation Strategy
- Whether Bavarian Nordic's aggressive share buyback signals confidence in its valuation or reflects limited organic growth opportunities.
- Market Sentiment
- How investors interpret the buyback program's pace and scale relative to the company's financial health.
- Regulatory Compliance
- The company's adherence to EU market abuse regulations during the repurchase period.
Related topics